2,310
-1.70%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Enseval Putera Megatrading Tbk PT
Its shares trade on IDX under the ticker EPMT.JK. It has been listed since 1 August 1994. In the fiscal year to 31 December 2025, it reported revenue of IDR 32.96trn and net income of IDR 789.19bn. At that date it held total assets of IDR 13.13trn and shareholders' equity of IDR 7.82trn.
PT Enseval Putera Megatrading Tbk engages in the distribution and supply of pharmaceutical, consumer, medical equipment, cosmetics and other trading products. The company is headquartered in Jakarta Timur, Dki Jakarta. The firm is engaged in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics and other trading products. Its business activities include distribution and sales of consumer products; prescription medicines; non-prescription medicines; raw materials for sale; medical equipment; veterinary and livestock medicines, and health care and transportation services. The company provides services across digital platforms, distribution and sales, health care, marketing and logistics. The company offers a range of products, such as consumer products, prescription and non-prescription medicines, raw materials, medical devices, clinics and veterinary products. The firm and its subsidiaries own 71 branches throughout Indonesia from Banda Aceh to Jayapura, supported by infrastructure to assist the operation of logistics.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 1 Aug 1994
- Employees
- 5,183
- Website
- enseval.com ↗
Leadership
Pay as last reported
- Mr. Budi Dharma WreksoatmodjoPresident Commissioner
- Mr. Jos Iwan AtmadjajaPresident Director
- Mr. Stanley Handiono AngkasaDirector
- Mr. Handi HalimDirector
- Mr. Sugianto ..Corporate Secretary
- Mr. Sanadi BoenjaminCommissioner
- Mr. Djonny Hartono TjahyadiCommissioner, since 2009
- Ms. Rosalina IrawatyIndependent Commissioner
- Ms. Lucky Surjadi SlametIndependent Commissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company has 5,183 employees and operates 71 branches across Indonesia.
- Engages in distribution and supply of pharmaceutical, consumer, medical equipment, and cosmetics products.
- Provides services across digital platforms, distribution, sales, health care, marketing, and logistics.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- No details on financial performance or market share provided.
- No information on competitive disadvantages or operational challenges.
Opportunities
- Expansion of digital platforms for distribution and sales services.
- Growth potential in health care and pharmaceutical markets in Indonesia.
- Utilization of existing infrastructure for logistics and branch expansion.
Threats
- No specific threats mentioned in the provided information.
- No details on market competition or regulatory challenges.
- No information on economic or industry-specific risks.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.